Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin/Ezetimibe Combination vs Rosuvastatin Monotherapy in Hypercholesterolemia
NCT02251847Phase 3Unknown
- Sponsor
- Ildong Pharmaceutical Co Ltd
- Start
- Jul 2014
- Primary completion
- Jul 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of rosuvastatin, ezetimibe in hypercholesterolemia, sponsored by Ildong Pharmaceutical Co Ltd. Status: unknown.
02
Drugs
rosuvastatinezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT02251847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02251847.